Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
EV/EBIT

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EV/EBIT(x) 38.870.260.94-0.11

What is the latest EV/EBIT ratio of CORONA REMEDIES ?

The latest EV/EBIT ratio of CORONA REMEDIES is 38.87 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar202638.87
Mar20250.26
Mar20240.94
Mar2023-0.11

How is EV/EBIT of CORONA REMEDIES Trending?

Years EV/EBIT % Change
Mar2026 38.87
14,850.00
Mar2025 0.26
-72.34
Mar2024 0.94
Positive
Mar2023 -0.11 -

Other Financial Ratios of CORONA REMEDIES


Compare EV/EBIT ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,815.6 Cr -0.8% 2.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,679.0 Cr -1.8% -7% 14.3% Stock Analytics
DIVIS LABORATORIES ₹246,408.0 Cr -3.4% 0.4% 58.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,634.0 Cr -2.7% -3.6% 36% Stock Analytics
CIPLA ₹109,063.0 Cr -3.9% -4.7% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,166.0 Cr 3% 6.1% -3.8% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.8%

2.3%

NA
SENSEX

-3.1%

-6.2%

-11.7%


You may also like the below Video Courses